Skip to content

Retained Earnings at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$18.29B+13.5%
CTO
Citius Oncology, Inc.CTOR
-$96.18M-79.2%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$279.63M-87.1%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
-$425.99M-11.6%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$4.36B-24.4%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$468.15M-22.1%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s retained earnings?
TuHURA Biosciences, Inc. (HURA) reported retained earnings of -$148.72M in Q1 2026.
How has TuHURA Biosciences, Inc.'s retained earnings changed year-over-year?
TuHURA Biosciences, Inc.'s retained earnings decreased by 26.3% year-over-year, from -$117.79M to -$148.72M.
What is the long-term trend for TuHURA Biosciences, Inc.'s retained earnings?
Over 3 years (2022 to 2025), TuHURA Biosciences, Inc.'s retained earnings has grown at a -0.8% compound annual growth rate (CAGR), from -$144.77M to -$141.18M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.